vs
Okta, Inc.（OKTA）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Okta, Inc.的季度营收约是Royalty Pharma plc的1.2倍（$742.0M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 5.8%，领先28.6%），Okta, Inc.同比增速更快（11.6% vs 4.8%），过去两年Okta, Inc.的营收复合增速更高（10.7% vs 4.6%）
Okta是总部位于美国旧金山的身份与访问管理服务商，成立于2009年，主打云软件产品，可助力企业管理和保障用户应用访问认证安全，同时支持开发者在应用、网站、网络服务及设备中嵌入身份管控功能，2017年上市时估值超60亿美元。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
OKTA vs RPRX — 直观对比
营收规模更大
OKTA
是对方的1.2倍
$622.0M
营收增速更快
OKTA
高出6.8%
4.8%
净利率更高
RPRX
高出28.6%
5.8%
两年增速更快
OKTA
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $742.0M | $622.0M |
| 净利润 | $43.0M | $214.2M |
| 毛利率 | 77.1% | — |
| 营业利润率 | 3.1% | 62.4% |
| 净利率 | 5.8% | 34.4% |
| 营收同比 | 11.6% | 4.8% |
| 净利润同比 | 168.8% | 2.9% |
| 每股收益（稀释后） | $0.24 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OKTARPRX
| Q4 25 | $742.0M | $622.0M | ||
| Q3 25 | $728.0M | $609.3M | ||
| Q2 25 | $688.0M | $578.7M | ||
| Q1 25 | $682.0M | $568.2M | ||
| Q4 24 | $665.0M | $593.6M | ||
| Q3 24 | $646.0M | $564.7M | ||
| Q2 24 | $617.0M | $537.3M | ||
| Q1 24 | $605.0M | $568.0M |
净利润OKTARPRX
| Q4 25 | $43.0M | $214.2M | ||
| Q3 25 | $67.0M | $288.2M | ||
| Q2 25 | $62.0M | $30.2M | ||
| Q1 25 | $23.0M | $238.3M | ||
| Q4 24 | $16.0M | $208.2M | ||
| Q3 24 | $29.0M | $544.0M | ||
| Q2 24 | $-40.0M | $102.0M | ||
| Q1 24 | $-44.0M | $4.8M |
毛利率OKTARPRX
| Q4 25 | 77.1% | — | ||
| Q3 25 | 76.9% | — | ||
| Q2 25 | 77.5% | — | ||
| Q1 25 | 76.8% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 76.0% | — | ||
| Q2 24 | 76.0% | — | ||
| Q1 24 | 76.0% | — |
营业利润率OKTARPRX
| Q4 25 | 3.1% | 62.4% | ||
| Q3 25 | 5.6% | 70.1% | ||
| Q2 25 | 5.7% | 36.3% | ||
| Q1 25 | 1.2% | 94.0% | ||
| Q4 24 | -2.4% | 60.9% | ||
| Q3 24 | -2.9% | — | ||
| Q2 24 | -7.6% | 50.2% | ||
| Q1 24 | -13.7% | -13.0% |
净利率OKTARPRX
| Q4 25 | 5.8% | 34.4% | ||
| Q3 25 | 9.2% | 47.3% | ||
| Q2 25 | 9.0% | 5.2% | ||
| Q1 25 | 3.4% | 41.9% | ||
| Q4 24 | 2.4% | 35.1% | ||
| Q3 24 | 4.5% | 96.3% | ||
| Q2 24 | -6.5% | 19.0% | ||
| Q1 24 | -7.3% | 0.8% |
每股收益（稀释后）OKTARPRX
| Q4 25 | $0.24 | $0.49 | ||
| Q3 25 | $0.37 | $0.67 | ||
| Q2 25 | $0.35 | $0.07 | ||
| Q1 25 | $0.15 | $0.55 | ||
| Q4 24 | $0.00 | $0.46 | ||
| Q3 24 | $0.15 | $1.21 | ||
| Q2 24 | $-0.24 | $0.23 | ||
| Q1 24 | $-0.26 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5B | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $6.9B | $9.7B |
| 总资产 | $9.2B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资OKTARPRX
| Q4 25 | $2.5B | $618.7M | ||
| Q3 25 | $2.9B | $938.9M | ||
| Q2 25 | $2.7B | $631.9M | ||
| Q1 25 | $2.5B | $1.1B | ||
| Q4 24 | $2.2B | $929.0M | ||
| Q3 24 | $2.4B | $950.1M | ||
| Q2 24 | $2.3B | $1.8B | ||
| Q1 24 | $2.2B | $843.0M |
总债务OKTARPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益OKTARPRX
| Q4 25 | $6.9B | $9.7B | ||
| Q3 25 | $6.8B | $9.6B | ||
| Q2 25 | $6.6B | $9.5B | ||
| Q1 25 | $6.4B | $9.8B | ||
| Q4 24 | $6.3B | $10.3B | ||
| Q3 24 | $6.1B | $10.3B | ||
| Q2 24 | $6.0B | $9.8B | ||
| Q1 24 | $5.9B | $9.9B |
总资产OKTARPRX
| Q4 25 | $9.2B | $19.6B | ||
| Q3 25 | $9.6B | $19.3B | ||
| Q2 25 | $9.4B | $18.3B | ||
| Q1 25 | $9.4B | $17.6B | ||
| Q4 24 | $9.0B | $18.2B | ||
| Q3 24 | $9.1B | $18.0B | ||
| Q2 24 | $9.0B | $17.7B | ||
| Q1 24 | $9.0B | $16.1B |
负债/权益比OKTARPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $218.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $214.0M | — |
| 自由现金流率自由现金流/营收 | 28.8% | — |
| 资本支出强度资本支出/营收 | 0.5% | — |
| 现金转化率经营现金流/净利润 | 5.07× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $904.0M | — |
8季度趋势，按日历期对齐
经营现金流OKTARPRX
| Q4 25 | $218.0M | $827.1M | ||
| Q3 25 | $167.0M | $702.6M | ||
| Q2 25 | $241.0M | $364.0M | ||
| Q1 25 | $286.0M | $596.1M | ||
| Q4 24 | $159.0M | $742.5M | ||
| Q3 24 | $86.0M | $703.6M | ||
| Q2 24 | $219.0M | $658.2M | ||
| Q1 24 | $174.0M | $664.6M |
自由现金流OKTARPRX
| Q4 25 | $214.0M | — | ||
| Q3 25 | $165.0M | — | ||
| Q2 25 | $240.0M | — | ||
| Q1 25 | $285.0M | — | ||
| Q4 24 | $158.0M | — | ||
| Q3 24 | $81.0M | — | ||
| Q2 24 | $218.0M | — | ||
| Q1 24 | $171.0M | — |
自由现金流率OKTARPRX
| Q4 25 | 28.8% | — | ||
| Q3 25 | 22.7% | — | ||
| Q2 25 | 34.9% | — | ||
| Q1 25 | 41.8% | — | ||
| Q4 24 | 23.8% | — | ||
| Q3 24 | 12.5% | — | ||
| Q2 24 | 35.3% | — | ||
| Q1 24 | 28.3% | — |
资本支出强度OKTARPRX
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.5% | — |
现金转化率OKTARPRX
| Q4 25 | 5.07× | 3.86× | ||
| Q3 25 | 2.49× | 2.44× | ||
| Q2 25 | 3.89× | 12.06× | ||
| Q1 25 | 12.43× | 2.50× | ||
| Q4 24 | 9.94× | 3.57× | ||
| Q3 24 | 2.97× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OKTA
| Subscription And Circulation | $724.0M | 98% |
| Technology Service | $18.0M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
